Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
37
ATRA Quote, Financials, Valuation and Earnings
Last price:
$11.27
Seasonality move
:
4.11%
Day range:
$9.86 - $11.47
52-week range:
$6.50 - $39.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.67x
P/B ratio:
--
Volume:
151.8K
Avg. volume:
101.9K
1-year change:
-17.62%
Market cap:
$65.7M
Revenue:
$8.6M
EPS (TTM):
-$25.76
Earnings Data
Next earnings date for ATRA
Mar 28
2025
Most recent earnings per share
-$2.93
Beat by $14.34
(Nov 12/2024)
Consensus Estimate
-$17.27
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ATRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/28/2025 | Q4 | $33.1M | -- | -- | -$2.34 | -- |
| 11/12/2024 | Q3 | $35.2M | $40.2M | -$2.93 | -$17.27 | $14.34 |
| 08/12/2024 | Q2 | $37.1M | $28.6M | -$3.10 | -$2.24 | -$0.86 |
| 05/09/2024 | Q1 | $24.7M | $27.4M | -$5.75 | -$6.42 | $0.67 |
| 03/28/2024 | Q4 | $14.3M | $4.3M | -$13.98 | -$12.05 | -$1.93 |
| 11/01/2023 | Q3 | -- | -- | -$16.40 | -$16.40 | -- |
| 08/08/2023 | Q2 | -- | -- | -$16.91 | -$16.51 | -$0.40 |
| 05/08/2023 | Q1 | -- | -- | -$18.00 | -$9.51 | -$8.49 |
| 02/08/2023 | Q4 | -- | -- | -$18.00 | -$9.70 | -$8.30 |
| 11/08/2022 | Q3 | -- | -- | -$20.50 | -$19.34 | -$1.16 |
| 08/08/2022 | Q2 | -- | -- | $4.50 | -- | -- |
| 05/05/2022 | Q1 | -- | -- | -$21.75 | -- | -- |
| 02/28/2022 | Q4 | -- | -- | -$24.00 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$22.50 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | -$22.75 | -- | -- |
| 05/04/2021 | Q1 | -- | -- | -$21.50 | -- | -- |
| 03/01/2021 | Q4 | -- | -- | -$23.75 | -- | -- |
| 11/09/2020 | Q3 | -- | -- | -$23.00 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$28.50 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | -$30.00 | -- | -- |
| 02/27/2020 | Q4 | -- | -- | -$34.00 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$32.75 | -- | -- |
| 08/08/2019 | Q2 | -- | -- | -$40.00 | -- | -- |
| 05/09/2019 | Q1 | -- | -- | -$36.00 | -- | -- |
| 02/26/2019 | Q4 | -- | -- | -$43.75 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | -$32.25 | -- | -- |
| 08/01/2018 | Q2 | -- | -- | -$28.75 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$26.25 | -- | -- |
| 02/27/2018 | Q4 | -- | -- | -$28.75 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -$25.50 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | -$23.50 | -- | -- |
| 05/04/2017 | Q1 | -- | -- | -$22.00 | -- | -- |
| 03/09/2017 | Q4 | -- | -- | -$15.75 | -- | -- |
| 11/04/2016 | Q3 | -- | -- | -$22.00 | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -$16.50 | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -$14.50 | -- | -- |
| 03/03/2016 | Q4 | -- | -- | -$18.75 | -- | -- |
| 11/11/2015 | Q3 | -- | -- | -$10.75 | -- | -- |
| 08/06/2015 | Q2 | -- | -- | -$15.50 | -- | -- |
| 05/28/2015 | Q1 | -- | -- | -$10.50 | -- | -- |
| 03/04/2015 | Q4 | -- | -- | -$16.75 | -- | -- |
Atara Biotherapeutics Earnings Questions
-
How Much did Atara Biotherapeutics Generate in Revenue Last Quarter?
Atara Biotherapeutics reported $40.2M worth of top line sales in its most recent quarter.
-
Did Atara Biotherapeutics Beat Earnings Last Quarter?
Atara Biotherapeutics announced earnings per share of -$2.93 which represents a beat of analyst forecast a -$17.27 per share.
-
Is Atara Biotherapeutics Profitable?
Atara Biotherapeutics reported $32.6M that represents $4.36 per share over the last quarter.
-
What is the Analyst Consensus for Atara Biotherapeutics EPS Next Year?
Atara Biotherapeutics's earnings are forecast to decrease from -$65.25 per share to -$62.69 per share next year representing a decrease of -91.07%.
-
When is Atara Biotherapeutics's Earnings Date?
Atara Biotherapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
